News|Articles|January 22, 2026
The Journey from Bench to Patient: Reach First-in-Human to Proof of Concept Trials with Speed, Safety, and Certainty
Author(s)Quotient Sciences
Partnering with an experienced first-in-human specialist such as Quotient Sciences is the key to navigating early development with confidence. Through our work with small molecules and biologics, we provide the expertise, infrastructure, and agility needed to move your novel therapy forward, faster.
Related Content
Trending on Applied Clinical Trials Online
1
Applying Systems Thinking to the Future of Clinical R&D
2
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
3
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5